Endovenous thermal ablation is one of the main minimally invasive treatment approaches for varicose veins caused by superficial venous reflux, particularly when the great saphenous vein, small saphenous vein or another suitable superficial truncal vein is incompetent.
The most established endovenous thermal techniques are Endovenous Laser Ablation (EVLA or EVLT) and Radiofrequency Ablation (RFA). Both treatments close an abnormal refluxing vein from inside using controlled thermal energy rather than removing the vein through traditional stripping surgery. Current vascular guidelines continue to recognise endovenous ablation as a major treatment option for appropriately selected symptomatic patients with truncal venous reflux.
Newer thermal technologies are also developing. Endovenous Microwave Ablation (EMA) has gained increasing research attention, while Endovenous Steam Ablation (EVSA) has also been studied as an alternative thermal technique. These methods should not, however, automatically be presented as equivalent to EVLA and RFA simply because they are newer. Evidence maturity, long-term durability, availability and specialist experience differ between technologies. A 2026 randomized trial described microwave ablation as an emerging treatment and found encouraging short-term results compared with EVLA, while also emphasizing the need for further long-term evaluation.
Why Thermal Ablation Should Start With a Doppler Map
A patient should not be booked for “laser treatment” simply because varicose veins are visible.
The visible vein on the calf or thigh may be only a branch of a larger refluxing venous pathway. Before thermal ablation is considered, duplex Doppler ultrasound should identify where abnormal reverse blood flow begins, which vein is responsible, how far reflux extends and whether the deep venous system is functioning appropriately.
This changes treatment.
For example, one patient may have long-segment great saphenous vein reflux extending from the groin toward the calf. Another may have short-segment reflux. Another may have small saphenous reflux behind the knee. A different patient may have large visible tributaries while the main saphenous trunk remains competent.
These patients should not automatically receive the same ablation.
Modern venous guidelines therefore place duplex ultrasound and anatomical assessment at the centre of treatment selection. Treatment should address a documented refluxing pathway rather than simply whichever vein is easiest to see.
What Happens to the Vein After Thermal Ablation?
A common patient concern is whether closing a vein will interfere with circulation.
The purpose of thermal ablation is to close a pathologically refluxing superficial vein that is no longer carrying blood efficiently in the intended direction.
Once the abnormal vein is closed, venous blood continues to return through functioning superficial and deep venous pathways.
The treated vein is not usually surgically pulled out. Instead, thermal energy damages the inner vein wall, causing the vein to collapse and eventually undergo fibrosis and gradual biological remodeling.
The aim is therefore not to remove blood circulation from the leg. It is to eliminate an abnormal reflux pathway that is contributing to venous hypertension and varicose veins.
Endovenous Laser Ablation (EVLA / EVLT)
Endovenous Laser Ablation, commonly called EVLA, EVLT or varicose vein laser treatment, uses laser energy delivered through a thin fibre placed inside the refluxing vein.
The procedure is usually performed under ultrasound guidance.
After the target vein is accessed through a small needle puncture, a guidewire and laser fibre are advanced to the planned treatment position. The position of the fibre is checked carefully before energy is delivered.
A solution of diluted local anaesthetic is usually injected around the target vein. This is known as tumescent anaesthesia.
Tumescent anaesthesia serves several purposes. It provides pain control, compresses the vein around the laser fibre and creates a protective fluid layer between the heated vein and surrounding tissues.
The laser fibre is then gradually withdrawn while controlled energy is delivered along the planned segment of vein.
EVLA has become an established alternative to traditional ligation and stripping for suitable superficial truncal venous reflux. A 2026 meta-analysis of randomized trials found broadly comparable anatomic success between EVLA, RFA and surgery for great saphenous vein incompetence, with similar patient-reported improvements across major treatment modalities.
Does the Type of Laser Matter?
Not every EVLA system is identical.
Laser wavelength, fibre design, energy delivery and procedural technique have evolved considerably since early endovenous laser systems.
Modern radial or multi-ring fibres are designed to distribute energy more evenly around the vein wall rather than concentrating energy in only one direction.
However, patients should be cautious about choosing treatment purely because a clinic advertises a particular wavelength or branded laser platform.
The more important questions are whether the patient has a clear indication for truncal ablation, whether the correct vein has been identified, whether treatment length and access have been planned properly, and whether the treating physician has appropriate experience.
Technology matters, but anatomy and treatment strategy matter more.
Radiofrequency Ablation (RFA)
Radiofrequency ablation uses the same broad endovenous principle as laser treatment but delivers controlled radiofrequency-generated thermal energy rather than laser energy.
A catheter is introduced into the refluxing vein under ultrasound guidance. After appropriate positioning and local anaesthetic preparation, sections of the vein are heated in a controlled manner so that the vein wall collapses and closes.
RFA has become another well-established treatment for suitable truncal reflux.
Current evidence does not support telling patients that one of the two major thermal methods is universally superior. The most recent randomized-trial synthesis found similar anatomic outcomes between EVLA and RFA, and current clinical guidelines treat both as established endovenous thermal approaches rather than defining a universal winner.
The choice may depend on anatomy, physician experience, available technology, previous treatment and patient-specific considerations.
EVLA or RFA: Which One Should a Patient Choose?
This is usually the wrong question to ask before Doppler assessment.
The first decision is whether thermal truncal ablation is appropriate at all.
If it is, EVLA and RFA can both offer effective treatment in suitable patients. Differences in procedural technique, equipment and individual recovery may influence the final decision, but the choice should be made after the venous anatomy is understood.
For some patients, neither may be the most appropriate method.
A very tortuous vein may make catheter advancement difficult. A vein that runs extremely close to the skin or to a vulnerable nerve may require particular caution. Previous procedures may have altered the anatomy. Other patients may be better suited to sclerotherapy, a non-thermal technique, phlebectomy or another strategy.
A good treatment plan therefore starts with “What needs to be treated?”, not “Which machine should we use?”
Endovenous Microwave Ablation (EMA)
Endovenous Microwave Ablation is a newer thermal technique that uses microwave energy to create controlled thermal injury within the target vein.
Interest in EMA has increased because it offers another catheter-based method for treating superficial truncal reflux.
Importantly, it is no longer accurate to describe microwave ablation as purely experimental. A multicentre randomized controlled trial published in 2026 compared EMA with EVLA in patients with great saphenous vein reflux. In that study, EMA was non-inferior to EVLA for six-month vein closure, with comparable improvement in clinical severity and quality-of-life measures. However, the investigators still described EMA as an emerging therapy and concluded that further research is needed to establish long-term durability.
This distinction is important for patients.
Promising early or intermediate results do not automatically mean that a newer treatment has the same depth of long-term evidence as techniques that have been studied across many years and many patient populations.
Healing Journey patients considering microwave ablation should therefore understand why EMA is being recommended instead of EVLA or RFA, what experience the treating centre has with the system, and what follow-up is planned.
Endovenous Steam Ablation (EVSA)
Endovenous Steam Ablation uses controlled steam pulses to produce thermal injury within the abnormal vein.
Unlike laser or radiofrequency systems, which deliver energy through direct thermal interaction from a fibre or catheter, steam can distribute thermal energy within the vein through heated vapour.
EVSA has been investigated in randomized studies and is a genuine endovenous treatment rather than a hypothetical technology. However, it remains considerably less common internationally than EVLA and RFA.
A 2026 meta-analysis that evaluated EVLA, RFA, EVSA and surgery found EVSA to be non-inferior to EVLA in the available randomized evidence, but the authors also concluded that additional long-term randomized data are needed.
For a patient, this means steam ablation can be a legitimate option in an experienced centre, but it should not be marketed as automatically superior simply because it is different or less common.
Established Treatment Versus Emerging Technology
One of the most confusing aspects of modern varicose vein treatment is that clinics may advertise technologies as though every new device represents a major medical advance.
That is not necessarily the case.
As of 2026, EVLA and RFA have the most established position within thermal endovenous ablation. They are supported by extensive clinical experience, randomized trials and major venous guidelines.
Microwave ablation is developing quickly and now has encouraging randomized data, but its long-term evidence base remains less mature.
Steam ablation also has randomized evidence but is less widely used, and recent evidence reviews continue to call for additional long-term data.
This is exactly why “newest” and “best” should never be treated as synonyms.
When Thermal Ablation May Not Be the Best Choice
Thermal ablation is highly useful, but it is not appropriate for every venous pattern.
The target vein needs to be accessible and suitable for catheter treatment. Its course, diameter, depth below the skin and relationship to nerves or other structures matter.
The patient’s broader medical history also matters.
Previous deep vein thrombosis, active superficial thrombosis, anticoagulant treatment, previous vein surgery, recurrent varicose veins, pregnancy, mobility limitations and other conditions can alter treatment planning.
In some patients, a non-thermal approach may provide practical advantages. In others, sclerotherapy, phlebectomy, vein-preserving treatment or conventional surgery may be preferable.
This is why a high-quality clinic should be willing to recommend something other than laser even if laser is one of its most frequently performed treatments.
What About the Visible Varicose Veins?
Closing a refluxing great or small saphenous vein does not necessarily make every visible varicose branch disappear immediately.
Some tributaries shrink after the underlying venous pressure is corrected.
Others remain prominent or symptomatic.
These veins may require mini-phlebectomy or sclerotherapy, either during the same treatment episode or later as part of a staged plan.
Current vascular guidelines specifically recognise the role of treating associated tributaries alongside or after truncal ablation when clinically appropriate.
This is another reason a patient should not judge the treatment plan solely by whether they are receiving “laser.”
The real question is whether the complete reflux pattern and symptomatic veins have been considered.
Possible Risks of Endovenous Thermal Ablation
EVLA and RFA are minimally invasive procedures, but they are not risk-free.
Temporary bruising, tenderness and a pulling or tight sensation along the treated vein can occur during recovery.
Other possible complications include superficial inflammation, pigmentation, sensory nerve irritation or numbness, skin injury and incomplete vein closure.
Thrombotic complications are uncommon but clinically important. Modern venous guidelines specifically address thrombus extension following endovenous ablation and recommend risk-based evaluation rather than treating every patient identically.
This is particularly relevant in patients with previous thrombosis, reduced mobility or other venous thromboembolism risk factors.
The purpose of discussing complications is not to make a generally minimally invasive procedure sound dangerous. It is to ensure that patients understand what monitoring and postoperative symptoms actually matter.
Recovery After EVLA or RFA
Many patients can walk shortly after endovenous thermal ablation and return to light daily activity relatively quickly.
Walking is generally encouraged because normal calf-muscle movement supports venous circulation.
However, recovery is not identical for everyone.
A patient undergoing treatment of one truncal vein may recover differently from a patient having bilateral thermal ablation combined with extensive phlebectomy.
Bruising, tenderness and local tightness may be more noticeable when additional tributaries are treated.
The treating team should provide individualized guidance regarding compression, exercise, prolonged standing, work, bathing, medication and follow-up rather than relying on a universal recovery timetable.
Endovenous Thermal Ablation Abroad
For an international patient, one of the biggest mistakes is arranging travel around a treatment name before the diagnosis has been finalized.
A patient may contact a clinic requesting laser varicose vein treatment in Türkiye, but photographs alone cannot confirm that EVLA is the correct procedure.
Whenever possible, previous duplex ultrasound studies, reports from earlier vein treatments, thrombosis history and current medications should be reviewed before travel.
If adequate current mapping is unavailable, the final plan may need to be confirmed after vascular examination and duplex Doppler assessment in Türkiye.
This means that an initial plan might appropriately state that the patient is potentially suitable for endovenous treatment, rather than guaranteeing EVLA, RFA or another technology before the responsible vein has been mapped.
That is good medical planning, not indecision.
Why Treatment Abroad Requires More Than the Procedure
Thermal ablation itself may be relatively short, but an international treatment pathway includes questions that a local patient may not need to consider in the same way.
The patient needs to know when walking can begin, whether compression is recommended, what symptoms require review, whether ultrasound follow-up is needed, and when return travel is appropriate.
The medical record should clearly identify which leg was treated, which vein and segment were ablated, which technique was used, whether tributary treatment was performed and what postoperative plan was recommended.
That information becomes particularly important if the patient develops recurrent symptoms or needs a vascular review after returning home.
Healing Journey’s role is therefore not simply to coordinate access to a laser or radiofrequency procedure. The aim is to help connect diagnostic review, specialist assessment, treatment selection, travel planning, recovery information and continuity of care after return home.
What Patients Should Not Assume About Thermal Ablation
Patients should not assume that every visible varicose vein requires laser.
They should not assume that RFA is automatically better because it uses a different energy source.
They should not assume that microwave or steam treatment is superior because it is newer or less familiar.
And they should not assume that successful closure of one saphenous vein means venous disease can never recur elsewhere.
The strongest treatment plan is not necessarily the one with the newest device.
It is the one that correctly identifies the source of reflux, selects an appropriate technique for that anatomy, treats clinically important tributaries when necessary and provides a realistic follow-up plan.
Why is Doppler mapping important before EVLA or RFA?
Doppler mapping identifies the source and extent of venous reflux, the vein that actually requires treatment, and anatomical factors that may influence whether thermal ablation is appropriate.
What should patients know before arranging thermal ablation abroad?
Patients should know which vein is expected to be treated, why EVLA, RFA or another technique is being recommended, whether additional treatment may be needed, what recovery and travel restrictions apply, and how follow-up will continue after returning home.
